Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
We’ve Been in a Bear Market for 9 Months: Is There Light at the End of the Tunnel?

We’ve Been in a Bear Market for 9 Months: Is There Light at the End of the Tunnel?

BitcoinSistemiBitcoinSistemi2026/07/01 20:42
By:BitcoinSistemi

As the effects of the bear market, which has lasted for approximately 9 months, continue, the cryptocurrency analysis company The DeFi Report evaluated Bitcoin’s on-chain data and macroeconomic outlook in its latest video report.

According to analyst Mike’s assessment, while the market is starting to show green lights for “buying,” the possibility that a definitive bottom has not yet been reached remains.

One of the most important technical indicators highlighted in the report is Bitcoin trading below its 200-week moving average (approximately $62,400). Analysts noted that the price is fluctuating between $59,000 and $60,000, adding that historically, Bitcoin hasn’t spent much time below these levels, and this generally signals a significant cycle bottom.

Four out of six key on-chain indicators (KPIs) tracked by The DeFi Report are currently giving a clear bullish signal:

  • Loss-Making Supply: More than 48% of the circulating Bitcoin supply is currently at a loss. Looking at the situation of long-term holders, it appears that the market is very close to the lows of past bear markets.
  • Missing Pieces: Two key indicators not giving a bullish signal are the Realized Market Value (RMV) and MVRV ratios. According to analysts, there hasn’t been enough “capital destruction” or change of hands in the market yet to fully confirm the final lows of past cycles.

Potential macroeconomic risks that could shake markets and trigger a final wave of capitulations in crypto assets are listed as follows:

  • Markets are pricing in a 70% probability of a potential interest rate hike in September. The Fed’s commitment to bringing inflation down to 2% could create renewed selling pressure in equity and crypto markets.
  • A sharp 20-25% pullback in NASDAQ or AI-focused technology stocks in general could drag the crypto market down with it.
  • Despite the Bank of Japan (BOJ) raising interest rates to 1%, the highest level in 30 years, the continued depreciation of the yen poses a significant risk. This could lead global investors to close their cheap carry trades, resulting in a liquidity crunch.

Increased political polarization ahead of the US elections and consumer confidence index hovering at historically low levels are putting indirect pressure on risky assets.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The "Outlier" Investment Art in the New Era of Berky

他山之石观投资2026/09/14 09:22
The "Outlier" Investment Art in the New Era of Berky

Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India

Chevron is focusing on Argentina and the Mediterranean region, seeking global growth in liquefied natural gas, and plans to reach an agreement with India.

智通财经2026/09/14 09:12
Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India

Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge

The upward pressure on energy prices caused by the unresolved Middle East war is mounting. New risks are also approaching, which may keep inflation above the Bank of England’s 2% target for most of next year.

智通财经2026/09/14 08:57
Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge

AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales

Bloomberg Intelligence analyst John Murphy stated that the setback in AstraZeneca's breast cancer drug trial could reduce sales in 2035 by $2.6 billion to $3.8 billion.

智通财经2026/09/14 08:41
AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales